Canada's private sector pharmaceutical R&D hits lowest level in 20 years: PMPRB
Guest ContributorSeptember 2, 2009
The 2007 increase in R&D intensity by Canada's patent-holding pharmaceutical firms appears to have been a temporary blip. New data from the Patented Medicines and Prices Review Board (PMPRB) show a decline in 2008 ratio of R&D outlays to sales revenue slipping to 8.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.